We therefore conclude that the IL-22-HOXB-AS5-PI3K/AKT functional axis may be one of the carcinogenic mechanisms of BC, serving as potential molecule biomarkers for diagnosis and therapy evaluation or targeted therapeutic strategy in BC. The gene discussed is AKT1; the disease is breast cancer.